A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.

Robin D TuckerVictor CiofoaiaSandeep NadellaMartha D GayHong CaoMatthew HuberAnita SafronenkaNarayan ShivapurkarBhaskar KallakuryAnnie J KrugerAlexander H K KroemerNicholas Osborne

Published in: Digestive diseases and sciences (2019)

These results support the novel role of CCK receptors in the pathogenesis of NASH and HCC.

Keyphrases

mouse model